Last Update 21:41
Sunday, 21 July 2019

Egypt's heath minister to agree with Hep C treatment company on second shipment

With a total of around 12 million Egyptians currently infected, each shipment will be used to treat only 70,000 patients with a total of 140,000 patients treated by June 2015

MENA, Ahram Online, Tuesday 23 Sep 2014
Share/Bookmark
Views: 1616
Share/Bookmark
Views: 1616

Egypt's health minister met on Tuesday with the chief executive officer of the company producing the Hepatitis C drug to discuss a second shipment, state news agency MENA reported.

Minister Adel Adawy met Gilead Company's chief executive officer, John C. Martin in his Cairo office, adding that the visit is a confirmation of continuing the distribution of the medicine in Egypt.

Egypt, which has the highest rate of Hepatitis C infections in the world, agreed with US pharmaceutical company, Gilead Sciences to receive a shipment of the new Hepatitis C (HCV) treatment, Sovaldi at a fraction of its market cost.

With a total of around 12 million Egyptians currently infected, each shipment will be used to treat only 70,000 patients with a total of 140,000 patients treated by June 2015.

So far, over 174,000 people have registered online for the drug.

Egypt's government has devised an online registration system for patients to register for the treatment. Priorities will be given to those with higher levels of liver deterioration.

On the sidelines of the meeting, Adawy confirmed to MENA that the first shipment of the medicine has reached Egypt fully.

He said that patients who registered for the treatment are currently being examined, and drugs would be given out to the optimal candidates starting in October.

The agreement with Gilead Sciences will provide the drug for one percent of its market price, LE2,200 ($300), according to a previous statement by the health ministry.

Short link:

 

Email
 
Name
 
Comment's
Title
 
Comment
Ahram Online welcomes readers' comments on all issues covered by the site, along with any criticisms and/or corrections. Readers are asked to limit their feedback to a maximum of 1000 characters (roughly 200 words). All comments/criticisms will, however, be subject to the following code
  • We will not publish comments which contain rude or abusive language, libelous statements, slander and personal attacks against any person/s.
  • We will not publish comments which contain racist remarks or any kind of racial or religious incitement against any group of people, in Egypt or outside it.
  • We welcome criticism of our reports and articles but we will not publish personal attacks, slander or fabrications directed against our reporters and contributing writers.
  • We reserve the right to correct, when at all possible, obvious errors in spelling and grammar. However, due to time and staffing constraints such corrections will not be made across the board or on a regular basis.
Latest

© 2010 Ahram Online.